Pre-Transplant Seroprevalence, Associated Factors, and PostTransplant Incidence of Toxoplasma gondii Infection Among Heart Transplant Recipients in Japan

被引:0
|
作者
Kanno, Yoshiaki [1 ]
Okamoto, Koh [1 ]
Shinohara, Takayuki [1 ]
Kinoshita, Osamu [2 ,3 ]
Hatano, Masaru [4 ]
Ikeda, Mahoko [1 ,5 ]
Harada, Sohei [5 ]
Okugawa, Shu [1 ]
Moriya, Kyoji [1 ,5 ]
Ono, Minoru [2 ,3 ]
Tsutsumi, Takeya [1 ,5 ]
机构
[1] Univ Tokyo Hosp, Dept Infect Dis, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo Hosp, Dept Heart Surg, Tokyo, Japan
[3] Tokyo Univ Hosp, Dept Organ Transplantat, Tokyo, Japan
[4] Univ Tokyo Hosp, Dept Geriatr Med, Tokyo, Japan
[5] Univ Tokyo Hosp, Dept Infect Control & Prevent, Tokyo, Japan
关键词
LONG-TERM SURVIVAL; RISK-FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE; PARASITIC INFECTIONS; ANTIBODY PREVALENCE; PREGNANT-WOMEN; SEROSTATUS; DONOR; PROPHYLAXIS; PREVENTION;
D O I
10.1016/j.transproceed.2023.11.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Among solid organ transplant (SOT) recipients, heart transplant (HT) recipients are at a higher risk of Toxoplasma gondii infection. As Toxoplasma seroprevalence varies by geographic location, updated local epidemiology is essential to guide preventive and therapeutic strategies. However, the Toxoplasma seroprevalence and incidence of post -transplant toxoplasmosis among SOT recipients in Japan are unknown. Methods. We performed a single -center retrospective observational study at an HT center in Tokyo, Japan. All HT recipients aged >= 18 years between 2006 and April 2019 were included. We reviewed patient charts and conducted a questionnaire survey to investigate the risk factors for infection. Results. Among 105 recipients included in the study, 11 (10.5%) were seropositive before transplant. Ninety-five recipients (90.5%), including all pre -transplant seropositive recipients, answered the questionnaire. The recipients who had lived in Okinawa (odds ratio [OR] 7.5 [95% CI 1.42-39.61]; P = .032) and who reported raw -meat eating habits (OR 4.64 [95% CI 1.0423.3]; P = .021) were more likely to be seropositive. None of the patients developed symptoms of toxoplasmosis. The post -transplant incidence of other major adverse outcomes was not signifi- cantly different according to the pre -transplant serostatus. Conclusions. About 10% of HT recipients at an HT center in Tokyo were seropositive for Toxoplasma pre -transplant, and none developed symptomatic toxoplasmosis post -transplant on trimethoprim-sulfamethoxazole. The history of raw meat consumption was associated with seropositivity; therefore, avoiding it might be recommended for HT recipient candidates.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 50 条
  • [21] Toxoplasma gondii infection among pregnant women in Yemen: Factors associated with high seroprevalence
    Al-Eryani, Samira M. A.
    Al-Mekhlafi, Abdulsalam M.
    Al-Shibani, Latifa A.
    Mahdy, Mohammed M. K.
    Azazy, Ahmed A.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (06): : 667 - 672
  • [22] Toxoplasma gondii serostatus is not an independent predictor of survival in heart transplant recipients: analysis of the Spanish Heart Transplant Registry
    Barge Caballero, E. Eduardo
    Almenar-Bonet, L.
    Mirabet-Perez, S.
    Rangel-Sousa, D.
    Segovia-Cubero, J.
    Gonzalez-Vilchez, F.
    Castel-Lavilla, Ma
    Diaz-Molina, B.
    Delgado-Jimenez, J.
    Sousa-Casasnovas, I.
    Lopez-Granados, A.
    De La Fuente-Galan, L.
    Gonzalez-Costello, J.
    Garrido-Bravo, Ip
    Blasco-Peiro, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 380 - 380
  • [23] Incidence and diagnosis of active toxoplasma infection among liver transplant recipients in western Turkey
    Caner, Ayse
    Doeskaya, Mert
    Karasu, Zeki
    Degirmenci, Aysu
    Guy, Edward
    Kilic, Murat
    Zeytunlu, Murat
    Francis, Janet
    Bozoklar, Ata
    Gueruez, Yueksel
    LIVER TRANSPLANTATION, 2008, 14 (10) : 1526 - 1532
  • [24] The Use of Intra-Aortic Balloon Pump Pre-Transplant Is Associated with Worse Outcomes in Heart Transplant Recipients
    Vucicevic, D.
    Honoris, L.
    Chang, A.
    Moreno, E.
    Salimbangon, A.
    Moore, M.
    Sweet, L.
    Shah, S.
    Iyengar, A.
    Pandya, K.
    Ardehali, A.
    Deng, M.
    DePasquale, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S304 - S304
  • [25] Clinical Outcomes of Lung Transplant Recipients with Pre-Transplant Mycobacterium Avium Complex Infection
    Kothadia, S.
    Cober, E.
    Koval, C.
    Benninger, L.
    Banzon, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1110 - S1111
  • [26] OUTCOMES OF PEDIATRIC HEART TRANSPLANT RECIPIENTS WITH ELEVATED PRE-TRANSPLANT PULMONARY VASCULAR RESISTANCE
    Sinha, Anjuli
    Boyle, Gerard
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 128 - 128
  • [27] Clinical outcomes of lung transplant recipients with pre-transplant Mycobacterium avium complex infection
    Kothadia, Sonya M.
    Cober, Eric E.
    Koval, Christine E.
    Golbin, Jem M.
    Harrington, Susan
    Miranda, Cyndee
    Benninger, Lauryn A.
    Banzon, Jona M.
    TRANSPLANT INFECTIOUS DISEASE, 2024,
  • [28] Associated risk factors for hepatitis E seroprevalence among liver transplant recipients
    Kujundzic, Petra Dinjar
    Dakovic, Oktavija Rode
    Vince, Adriana
    Prpic, Jelena
    Jemersic, Lorena
    Kolaric, Branko
    Ostojic, Ana
    Mrzljak, Anna
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E719 - E720
  • [29] PRE-TRANSPLANT FACTORS INFLUENCING RATES OF HEPATOCELLULAR CARCINOMA RECURRENCE IN LIVER TRANSPLANT RECIPIENTS
    Zucker, Kelly
    Gomez, Paul
    Kezirian, Olivia
    Fallon, Michael B.
    Mehta, Shivang
    HEPATOLOGY, 2020, 72 : 648A - 648A
  • [30] Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
    Zucker, Kelly M.
    Gomez, Paul A.
    Kezirian, Olivia
    Mehta, Shivang
    GASTROENTEROLOGY RESEARCH, 2021, 14 (03) : 190 - 193